DELEGENTRAA focused venture.
Evidence before scale.
Delegentra’s initial commercial hypothesis and the milestones we are working to validate.
Evidence-linked technical and commercial decision packs for B2B technology teams.
Recurring vendor decisions pull information from proposals, technical documents and team judgment. Our first pilot aims to deliver a source-linked comparison, explicit assumptions and a useful expert-reviewed handoff.
| Proof sought | What we plan to measure | Current evidence |
|---|---|---|
| Paid need | Budget owner, paid pilot and repeat use | Not yet measured |
| Useful output | Acceptance time, source accuracy and revision effort | Not yet measured |
| Delivery economics | Model, tools and human review cost per accepted output | Not yet measured |
| Repeatable product | Second-customer setup effort and reused workflow | Not yet measured |
| Customer deployment | Identity, data isolation and tested operating controls | Open work; see readiness page |
Proposed first 90 days
Understand
20 qualified problem conversations and a narrow pilot offer.
Deliver
A target of 2–3 paid pilots with agreed acceptance and data scope.
Demonstrate
At least one repeat-use signal, measured delivery economics and a documented customer deployment path.
These are goals, not completed milestones, forecasts or commitments. The prototype has no production customer or funding claims. Target round size and valuation have not been set.
Studio supports expert-led implementation and early pilots. Intelligence is the product hypothesis. Labs holds personal research; IoT/Edge is a later customer-led expansion under the same brand.